Global Non-Therapeutic Biomolecules Market Size By End User(Research, Pharma and IVD), By IVD Moleculaire(Oligonucleotides, Plasmids and Enzymes), By IVD IA(Recombinant Proteins, Plasmids, Enzymes), By Pharma ATM(Recombinant Proteins and Plasmids), By Trad Pharma(Enzymes, Recombinant Proteins), By Pharma CRO(Enzymes, Recombinant Proteins), By Trad Pharma(Enzymes, Recombinant Proteins, Plasmids), B

Non-Therapeutic Biomolecules Market Size And Forecast

Non-Therapeutic Biomolecules Market size was valued at USD 23,106.76 Million in 2020 and is projected to reach USD 48,005.55 Million by 2028, growing at a CAGR of 10.13% from 2021 to 2028.

The increasing government investments and R&D expenditure in the pharmaceutical and biochemical companies are expected to propel high demand for the Global Non-Therapeutic Biomolecules Market. The Non-Therapeutic Biomolecules Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

>>> Get | Download Sample Copy @ –

What is Non-Therapeutic Biomolecules?

Non-therapeutic biomolecules are those molecules that are required and are important for biological processes and these are present in organisms. These perform various functions, like development or cell division, etc. These non-therapeutic biomolecules are present in living organisms and are a vital part of them as they are already produced inside these organisms. But they also need some extra molecules to survive. These extra biomolecules may include external nutrients. The non-therapeutic molecules include very large biomolecules in them, like carbohydrates, proteins, and acids, and they also include small biomolecules too.

Global Non-Therapeutic Biomolecules Market Overview

The increasing government investments and R&D expenditure in the pharmaceutical and biochemical companies are expected to propel high demand for the Global Non-Therapeutic Biomolecules Market. Rapidly increasing use on non-therapeutic molecules in various applications like research, laboratory testing, etc. like catalyzing the biochemical reaction, in DNA purification and synthesis, etc. is also forecasted to boost the growth of the market. The market’s growth is anticipated to be hampered by issues such as often changing regulatory laws for the biotechnology industry and a shortage of experienced personnel in the biotechnology sector.

Global Non-Therapeutic Biomolecules MarketSegmentation Analysis

The Global Non-Therapeutic Biomolecules Market is segmented based on End User, IVD Moleculaire, IVD IA, Pharma ATM, Trad Pharma, Pharma CRO, Research and Geography.

Non-Therapeutic Biomolecules Market by End User

• Research
• Pharma
• IVD

Based on End User, the market is bifurcated into Research, Pharma and IVD. Research accounted for the largest market share of 46.00% in 2020, with a market value of USD 10,628.51 Million and is projected to grow at the highest CAGR of 10.65% during the forecast period. Pharma was the second-largest market in 2020, valued at USD 7,879.29 Million in 2020; it is projected to grow at a CAGR of 9.97%.

Non-Therapeutic Biomolecules Market by IVD Moleculaire

• Oligonucleotides
• Plasmids
• Enzymes

Based on the IVD Moleculaire, the market is bifurcated into Oligonucleotides, Plasmids and Enzymes. Oligonucleotides accounted for the largest market share of 40.38% in 2020, with a market value of USD 659.67 Million and is projected to grow at the highest CAGR of 9.13% during the forecast period. Plasmids was the second-largest market in 2020, valued at USD 568.74 Million in 2020; it is projected to grow at a CAGR of 8.92%.

Non-Therapeutic Biomolecules Market by IVD IA

• Recombinant Proteins
• Plasmids
• Enzymes
• Monoclonal Antibodies
• Peptides

Based on the IVD IA, the market is bifurcated into Recombinant Proteins, Plasmids, Enzymes, Monoclonal Antibodies and Peptides. Recombinant Proteins accounted for the largest market share of 35.65% in 2020, with a market value of USD 1,056.99 Million and is projected to grow at the highest CAGR of 9.63% during the forecast period. Plasmids was the second-largest market in 2020, valued at USD 795.94 Million in 2020; it is projected to grow at a CAGR of 9.40%.

Non-Therapeutic Biomolecules Market by Pharma ATM

• Recombinant Proteins
• Plasmids

Based on the Pharma ATM, the market is bifurcated into Recombinant Proteins and Plasmids. Recombinant Proteins accounted for the largest market share of 63.75% in 2020, with a market value of USD 1,287.68 Million and is projected to grow at the highest CAGR of 10.14% during the forecast period. Total was the second-largest market in 2020, valued at USD 1,825.64 Million in 2020; it is projected to grow at a CAGR of 9.59%.

Non-Therapeutic Biomolecules Market by Trad Pharma

• Enzymes
• Recombinant Proteins
• Peptides
• Monoclonal Antibodies

Based on the Trad Pharma, the market is bifurcated into Enzymes, Recombinant Proteins, Peptides and Monoclonal Antibodies.Enzymes accounted for the largest market share of 32.15% in 2020, with a market value of USD 845.92 Million and is projected to grow at the highest CAGR of 10.16% during the forecast period. Recombinant Proteins was the second-largest market in 2020, valued at USD 725.29 Million in 2020; it is projected to grow at a CAGR of 9.97%.

Non-Therapeutic Biomolecules Market by Pharma CRO

• Enzymes
• Recombinant Proteins
• Peptides
• Monoclonal Antibodies

Based on the Trad Pharma, the market is bifurcated into Enzymes, Recombinant Proteins, Peptides and Monoclonal Antibodies.Enzymes accounted for the largest market share of 29.76% in 2020, with a market value of USD 1,018.38 Million and is projected to grow at the highest CAGR of 10.72% during the forecast period. Recombinant Proteins was the second-largest market in 2020, valued at USD 1,001.25 Million in 2020; it is projected to grow at a CAGR of 10.34%.

Non-Therapeutic Biomolecules Market by Trad Pharma

• Enzymes
• Recombinant Proteins
• Plasmids
• Peptides
• Oligonucleotides
• Monoclonal Antibodies

Based on the Trad Pharma, the market is bifurcated into Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, and Monoclonal Antibodies. Enzymes accounted for the largest market share of 21.98% in 2020, with a market value of USD 2,335.70 Million and is projected to grow at the highest CAGR of 11.08% during the forecast period. Oligonucleotides was the second-largest market in 2020, valued at USD 1,379.94 Million in 2020; it is projected to grow at a CAGR of 10.34%.

Non-Therapeutic Biomolecules Market by Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, the Global Non-Therapeutic Biomolecules Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market share of 34.70% in 2020, with a market value of USD 8,019.13 Million and is projected to grow at a CAGR of 10.24% during the forecast period. Asia Pacific was the second-largest market in 2020, valued at USD 7,430.92 Million in 2020; it is projected to grow at the highest CAGR of 10.74%.

Key Players

The “Global Non-Therapeutic Biomolecules Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Merck KGaA, Bio-Techne Corporation, Bio-synthesis Inc., Aviva Systems Biology Corporation, RayBiotech Life Inc., Biocon, Eurogentec and others.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our 

Reasons to Purchase this Report

We'll take a deep dive into the market using both qualitative and quantitative analysis, looking at economic and non-economic factors to understand different customer segments. You'll get the market value (in USD Billion) for every segment and sub-segment, plus we'll point out the region and segment poised for the fastest growth and market dominance. Expect a geographic breakdown analyzing product/service consumption and the key factors influencing each region. The competitive landscape will be mapped out, ranking major players and highlighting new launches, partnerships, expansions, and acquisitions over the last five years. You'll receive extensive company profiles, including overviews, insights, product benchmarking, and SWOT analysis for key players. We'll also give you a current and future market outlook, factoring in recent developments like growth opportunities, drivers, challenges, and restraints in both emerging and developed regions. An in-depth analysis through Porter's Five Forces will give you different perspectives on the market, and we'll provide insight into the Value Chain. Finally, we'll lay out the market dynamics and growth opportunities on the horizon, all backed by 6 months of post-sales analyst support.

Customization of the Report

In case of any please connect with our sales team, who will ensure that your requirements are met.